News - Page 86 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article MindMed Announces Pricing of Public Offering of Common Shares and Warrants

MindMed Announces Pricing of Public Offering of Common Shares and Warrants

Post published:September 28, 2022
Post category:Press Release

Read more about the article Mindset Pharma Provides Strategic Intellectual Property License to Cybin

Mindset Pharma Provides Strategic Intellectual Property License to Cybin

Post published:September 28, 2022
Post category:Press Release

Read more about the article Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock

Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock

Post published:September 28, 2022
Post category:Press Release

Read more about the article MindMed Announces Proposed Public Offering of Common Shares

MindMed Announces Proposed Public Offering of Common Shares

Post published:September 28, 2022
Post category:Press Release

Read more about the article BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives

BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives

Post published:September 27, 2022
Post category:Press Release

Read more about the article atai Life Sciences Announces Initiation of Phase 1 Trial for its MDMA Derivative, EMP-01

atai Life Sciences Announces Initiation of Phase 1 Trial for its MDMA Derivative, EMP-01

Post published:September 27, 2022
Post category:Press Release

Read more about the article Clearmind Announces Notice of Proposed Stock Consolidation

Clearmind Announces Notice of Proposed Stock Consolidation

Post published:September 26, 2022
Post category:Press Release

Read more about the article MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT AND WELCOMES NEW CFO

MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT AND WELCOMES NEW CFO

Post published:September 24, 2022
Post category:Press Release

Read more about the article Clearmind Applies for Patent to Treat Obesity and Metabolic Syndrome

Clearmind Applies for Patent to Treat Obesity and Metabolic Syndrome

Post published:September 23, 2022
Post category:Press Release

Read more about the article Delix Therapeutics Expands World-Class Team with First Head of R&D

Delix Therapeutics Expands World-Class Team with First Head of R&D

Post published:September 23, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.